Product Details
Zytiga 250mg Tablets#
Abiraterone Acetate250 mg
Tablet
ROA
Oral
Applicant Name
J & J Company West Africa Limited
NRN
B4-8220
Status
Active
Composition
ATC Code
L02BX0
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 X 120
Product Description
95 RNW-PP-306499 Zytiga 250mg Tablets ABIRATERONE ACETATE Each tablet contains 250 mg abiraterone acetate, other ingredients inlcude microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone (K29/K32), colloidal anhydrous silica, and sodium laurilsulfate (see section 2, “ZYTIGA contains lactose and sodium”). B4-8220 Drugs ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS Imported Products 120*1 POM 2 1/10/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 DL-CONZACTCTRegulatoryAffairs@JNJZA.JNJ.com PATHEON INC., 2100 SYNTEX COURT, MISSISSAUGA, ONTARIO, CANADA, L5N 7K9, Canada
Manufacturer Name
Patheon Inc.
Manufacturer Country
CANADA
Approval Date
2023-03-28
Expiry Date
2028-03-27